Iambic Prices IPO at $16 per Share
Iambic Therapeutics priced its initial public offering of 9,375,000 common shares at $16.00 per share.
Story updates
10:53:35 PM UTC
SquawkNews
Iambic Therapeutics priced its IPO at $16 per share for 9,375,000 shares, for expected gross proceeds of $150.0M. Shares are expected to begin trading on Oct. 15, 2026 on Nasdaq under “IAM”; underwriters have a 30-day option for up to 1,406,250 additional shares.Material DetailsContext by AI Analys…
Iambic Therapeutics, Inc. 00 per shar…